Department of Veterans Affairs, Office of Research and Development (VA)

Agency/Department

FLC Region

Security Lab

No

Address

810 Vermont Ave (NW)
Washington, DC 20420
United States

Laboratory Representative

Description

 

VA’s Research and Development program (VA Research), with its distinguished history of discovery and innovation dating back to 1925, today remains an essential part of VA’s efforts to ensure the health and wellbeing of our nation’s Veterans. The fundamental mission of VA Research is to advance the health and care of Veterans. It is part of the Veterans Health Administration, America’s largest integrated health care systems with over 1,700 sites of care, serving 8.3 million Veterans each year. With a state of-the-art electronic health record, VA Research is uniquely positioned to conduct pioneering research.

 

With the unique combination of accessible data, a national research setting with linked infrastructure, and a large research population, VA Research is renowned for conducting large-scale clinical trials and comparative effectiveness research. With more than 70 percent of VA researchers also providing care to patients, the program is poised to quickly move innovations and discoveries from the research setting to the care setting. Findings from clinical research, considered with findings from genomics and health services research, VA Research provides evidence-based information that can be used to enhance VA’s ability to provide personalized health care, care tailored to a specific patient’s circumstances. By giving VA providers such evidence-based information about an intervention’s effectiveness, the research helps guide providers as they consider various health care options and inform patients to participate in care decisions.

Mission

The Office of Research and Development (ORD) aspires to discover knowledge, develop VA researchers and health care leaders, and create innovations that advance health care for our Veterans and the Nation. ORD is headquartered in Washington, DC and has an estimated 3,000 investigators and 10,000 research staff located at 119 VA Medical Centers (VAMCs around the country. VA Research is an intramural research program that also embraces its close ties with academic affiliates, other federal agencies, nonprofit organizations, and private industry. By partnering with others who have common research interests, VA Research is able to leverage resources and expand the impact of federal research investments.

ORD consists of four research services that together form a cohesive whole to explore all phases of veterans' healthcare needs. Each Service oversees a number of world renowned research centers nationwide.

The Biomedical Laboratory Research & Development Service conducts research that explores basic biological or physiological principles in humans or animals but does not involve intact human beings. For example, it includes research on animal models and investigations of tissues, blood or other biologic specimens from humans

The Clinical Science Research and Development Service conducts research that focuses on intact human beings as the unit of examination. Examples include interventional and effectiveness studies, clinical, epidemiological and technological studies.

The Health Services Research and Development Service pursues research at the interface of health care systems, patients and health care outcomes. HSR&D underscores all aspects of VA health care; specifically quality, access, patient outcomes and health care costs.

The Rehabilitation Research & Development Service is dedicated to the well-being of America's veterans through a full spectrum of research: from approved rehabilitation research projects, through evaluation and technology transfer to final clinical application.

Each of these four services is headed by a director who is supervised by the Chief Research and Development Officer (CRADO), who in turn reports to the Deputy Under Secretary for Health for Policy and Services.

Tech Areas

Available Technologies
Displaying 1 - 10 of 271
A High Current, Radio Frequency Coupled Microstimulator for Autonomic Applications
A Surgically Implantable Urinary Incontinence Device
Acridone compounds
Acridone compounds
Activating extraction of demineralized bone matrix
Activation of quiescent stem cells
Acyl CoA:cholesterol acyltransferase (ACAT-2)
Administration of 3,5-diiodothyropropionic acid for stimulating weight loss, and/or lowering triglyceride levels, and/or treatment of metabolic syndrome
Alpha B-crystallin as a therapy for ischemia or inflammation
Amino acid sequences which enhance peptide conjugate solubility

Pages

No Funding for this lab
No Programs for this lab
No Facilities for this lab
No Equipment for this lab
No publications for this lab
No awards for this lab
Notices
Agency
Department of Veterans Affairs, Office of Research and Development (VA)
Action:
Intent
Publication DateOct 04, 2019
Notice is hereby given that the Department of Veterans Affairs (VA), Office of Research and Development, Technology Transfer Program, intends to grant to LEVO USA, INC., 7105 Northland Terrace, Brooklyn Park, MN, 55428, an exclusive license to U.S. Patent No. 9,044,369 and U.S. Patent No. 9,101,520 associated with VA Invention Disclosure number 10-151 titled, “Mobile Manual Standing Wheelchair”.
Dates:
Comments must be received on or before October 20, 2019.
Address:
Send comments to Mr. Ryan Davis, Technology Transfer Specialist, Office of Research and Development (10X2TT), Department of Veterans Affairs, 810 Vermont Avenue, NW., Washington, DC 20420, (202) 632-7554 (this is not a toll-free number), ryan.davis7@va.gov.
For further information contact:
Mr. Ryan Davis, Technology Transfer Specialist, Office of Research and Development (10X2TT), Department of Veterans Affairs, 810 Vermont Avenue, NW., Washington, DC 20420, (202) 632-7554 (this is not a toll-free number), ryan.davis7@va.gov.
Supplementary information:
The Federal Government’s patent rights in this invention are assigned to the US Government as represented by the Department of Veterans Affairs. It is in the public interest to license this invention as Levo USA, Inc. has submitted a complete and sufficient application for a license. The prospective exclusive license will be royalty-bearing and will comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7. The prospective exclusive license may be granted unless, within 15 days from the date of this published Notice, the Department of Veterans Affairs Office of Research and Development, Technology Transfer Program receives written evidence and argument which establishes that the grant of the license would not be consistent with the requirements of 35 U.S.C. 209 and 37 CFR 404.7. JOHN J KAPLAN Director, Technology Transfer Program Office of Research and Development
Correction:
Send Inquiry
Agency
Department of Veterans Affairs, Office of Research and Development (VA)
Action:
Intent
Publication DateOct 04, 2019
Notice is hereby given that the Department of Veterans Affairs (VA), Office of Research and Development, Technology Transfer Program, intends to grant to LEVO USA, INC., 7105 Northland Terrace, Brooklyn Park, MN, 55428, an exclusive license to U.S. Patent No. 9,044,369 and U.S. Patent No. 9,101,520 associated with VA Invention Disclosure number 10-151 titled, “Mobile Manual Standing Wheelchair”.
Dates:
Comments must be received on or before October 20, 2019.
Address:
Send comments to Mr. Ryan Davis, Technology Transfer Specialist, Office of Research and Development (10X2TT), Department of Veterans Affairs, 810 Vermont Avenue, NW., Washington, DC 20420, (202) 632-7554 (this is not a toll-free number), ryan.davis7@va.gov.
For further information contact:
Mr. Ryan Davis, Technology Transfer Specialist, Office of Research and Development (10X2TT), Department of Veterans Affairs, 810 Vermont Avenue, NW., Washington, DC 20420, (202) 632-7554 (this is not a toll-free number), ryan.davis7@va.gov.
Supplementary information:
The Federal Government’s patent rights in this invention are assigned to the US Government as represented by the Department of Veterans Affairs. It is in the public interest to license this invention as Levo USA, Inc. has submitted a complete and sufficient application for a license. The prospective exclusive license will be royalty-bearing and will comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7. The prospective exclusive license may be granted unless, within 15 days from the date of this published Notice, the Department of Veterans Affairs Office of Research and Development, Technology Transfer Program receives written evidence and argument which establishes that the grant of the license would not be consistent with the requirements of 35 U.S.C. 209 and 37 CFR 404.7. JOHN J KAPLAN Director, Technology Transfer Program Office of Research and Development
Correction:
Send Inquiry
No success stories for this lab
Submit an Success Story